TREATMENT OF INTRACRANIAL HYPERTENSION
TREATMENT OF INTRACRANIAL HYPERTENSION
复制标题
DOI:
10.1007/bf01405391
复制
发表时间:
1977-01-01
影响因子:
2.4
通讯作者:
GHOSTINE, SY
中科院分区:
文献类型:
--
作者:
JAMES, HE;LANGFITT, TW;GHOSTINE, SY
Consecutive recordings (105) of intracranial pressure (ICP) were made in 95 patients over a 3 yr period, using a Scott cannula inserted through a burr hole or a twist drill hole into the anterior horn of the lateral ventricle. The clinical diagnoses were head injury, intracranial tumor, aneurysm and arteriovenous malformation, brain swelling secondary to systemic disease and brain swelling of unknown etiology. ICP exceeded 20 mm Hg in 86 of the recordings (maximum 110 mm Hg). Hypertonic mannitol was administered 73 times in 48 patients. ICP was reduced 10% or more (mean 52%) in all but 3 administrations. The effect of hyperventilation was tested in 50 trials in 34 patients. ICP was reduced 10% or more (mean 47%) in 34 trials. The mean time to maximum reduction of ICP was 8 min, and ICP returned to control almost immediately after cessation of hyperventilation. Hypothermia was studied in 40 trials in 40 patients. ICP was reduced 10% or more (mean 51%) in half the patients. The infection rate was 6.3% in 4 hospitals, but 4 of the 6 infections were in 1 hospital. If this hospital were excluded, the infection rate was 3.1%.